Stoke Therapeutics, Inc. Common Stock
STOK Real Time Price USDRecent trades of STOK by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by STOK's directors and management
Government lobbying spending instances
-
$30,000 Jan 19, 2023 Issue: Health Issues
-
$30,000 Oct 20, 2022 Issue: Health Issues
-
$30,000 Jul 19, 2022 Issue: Health Issues
-
$30,000 Apr 19, 2022 Issue: Health Issues
Estimated quarterly lobbying spending
STOK Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Methods and compositions for treatment of cholesteryl ester storage disease Aug. 13, 2024
-
Patent Title: Antisense oligomers for treatment of conditions and diseases Jan. 16, 2024
-
Patent Title: Opa1 antisense oligomers for treatment of conditions and diseases Nov. 14, 2023
-
Patent Title: Antisense oligomers and uses thereof Aug. 24, 2021
-
Patent Title: Antisense oligomers for treatment of conditions and diseases Feb. 09, 2021
-
Patent Title: Antisense oligomers for treatment of conditions and diseases Jun. 16, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to STOK
Number of mentions of STOK in WallStreetBets Daily Discussion
Recent picks made for STOK stock on CNBC
ETFs with the largest estimated holdings in STOK
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view STOK Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.